Tirtha Chakraborty
2022
In 2022, Tirtha Chakraborty earned a total compensation of $1.9M as Chief Scientific Officer at Vor Biopharma, a 250% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $172,602 |
|---|---|
| Option Awards | $866,470 |
| Salary | $430,000 |
| Stock Awards | $403,560 |
| Other | $20,353 |
| Total | $1,892,985 |
Chakraborty received $866.5K in option awards, accounting for 46% of the total pay in 2022.
Chakraborty also received $172.6K in non-equity incentive plan, $430K in salary, $403.6K in stock awards and $20.4K in other compensation.
Rankings
In 2022, Tirtha Chakraborty's compensation ranked 1,847th out of 5,756 executives tracked by ExecPay. In other words, Chakraborty earned more than 67.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,847 out of 5,756 | 68th |
Division Manufacturing | 969 out of 3,133 | 69th |
Major group Chemicals And Allied Products | 400 out of 1,419 | 72nd |
Industry group Drugs | 365 out of 1,320 | 72nd |
Industry Biological Products, Except Diagnostic Substances | 91 out of 291 | 69th |
Source: SEC filing on April 14, 2023.
Chakraborty's colleagues
We found two more compensation records of executives who worked with Tirtha Chakraborty at Vor Biopharma in 2022.